线性MTH1抑制剂TH1579通过cGAS-STING通路诱导PD-L1表达和炎症反应
Jianyu Shen1, Emilio Guillén Mancina1, Shenyu Chen1
1Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Oncogenesis
|May 25, 2024
概括
新型MTH1抑制剂TH1579通过调节PD-L1并增强免疫反应来增强癌症免疫疗法. 这种双重作用药物在改善免疫检查点抑制剂疗效方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫检查点抑制剂 (ICI) 治疗疗效通常是有限的.
- 破坏DNA的药物可以通过cGAS-STING通路增强ICI反应.
- MTH1 抑制剂向氧化 DNA 损伤和线粒分裂.
研究的目的:
- 调查MTH1抑制剂TH1579是否可以增强ICI疗效.
- 为了探索TH1579.的免疫调节特性.
- 评估TH1579对PD-L1表达和免疫细胞透的影响.
主要方法:
- 用TH1579.9治疗人类和小鼠癌症细胞系.
- 使用流式细胞计和qPCR分析PD-L1和化学激素表达.
- 在体内研究中,使用TH1579和抗PD-L1抗体 (atezolizumab) 的同源性老鼠黑色素瘤模型.
主要成果:
- TH1579在人类癌细胞系中提高了PD-L1表达的调节.
- 结合TH1579和阿特佐利祖马布在小鼠模型中显著改善了抗瘤疗效.
- TH1579增加了依赖cGAS-STING通路的促炎性细胞因子 (IFN-β) 和化学因子 (CCL5,CXCL10).
结论:
- TH1579证明了可以增强ICI治疗的免疫调节作用.
- 该药物上调PD-L1并激活cGAS-STING通路,这表明它在改善癌症免疫疗法方面发挥了作用.
- TH1579具有作为辅助疗法的潜力,可以克服对免疫检查点阻塞的抵抗力.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


